Epanutin Infatabs 50mg Chewable Tablets
Authorisation PA23355/050/005 · Viatris Healthcare Limited
- Licence holder
- Viatris Healthcare Limited (all products →)
- Active substance
- Phenytoin
- Clinical trials
- 5 clinical trials →
- Dosage form
- Chewable tablet
- Route of administration
- Oral use
- ATC codes
- N03AB, N03AB02
- First authorised
- 09/05/1975
- Prescription status
- Product subject to prescription which may be renewed (B)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
Phenytoin: supply and approvals
8 authorised products on the HPRA list contain Phenytoin. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 17 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 17 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 17 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 51 years (since 9 May 1975). The HPRA list marks it as marketed in Ireland.
Other medicines with Phenytoin in Ireland
1 other product on the HPRA list contains Phenytoin, from 1 licence holder; 1 of them is marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Epanutin 30 mg/5ml Oral Suspension | Viatris Healthcare Limited | National authorisation (PA) | Marketed |
Other substances in ATC group N03AB
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 2 other active substances share the group N03AB with this product:
PHENYTOIN SODIUM (6) · Fosphenytoin sodium (1)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Viatris Healthcare Limited holds 155 products on the HPRA list, with 72 different active substances; 110 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 18 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.